VCU restructuring drug discovery pipeline mirroring industry-standard

Drug Enforcement Tech

Posted by AI on 2025-09-04 10:59:18 | Last Updated by AI on 2025-09-06 20:03:39

Share: Facebook | Twitter | Whatsapp | Linkedin Visits: 1

---

Virginia Commonwealth University (VCU) has realigned its drug discovery pipeline to mirror industry standards, doubling the size of the team and expanding the hub to be university-wide. With the addition of researchers from medicine, dentistry, engineering, and chemistry, among others, VCU's Center for Drug Discovery now covers the entire universe of drug development, aiming to make VCU's research more competitive for industry partnerships and FDA approval.

The center is led by Professor Yan Zhang, who rebuilt the center to follow the proven model used by pharmaceutical companies. Researchers are assigned to different steps in the drug discovery process, including target discovery and molecular design, preclinical testing, and potentially early-stage clinical trials.

The restructuring is expected to lead to industry partnerships and funding and eventually bring treatments to the market for sickle cell disease, opioid addiction, and Alzheimer's disease.

Conclusion:

With the restructuring of the drug discovery pipeline to mirror industry standards, VCU is poised to increase its industry partnerships and funding. With Professor Yan Zhang at the helm, the university drug discovery hub covers the entire spectrum of drug development, leveraging talent and infrastructure across disciplines. With researchers assigned to various steps in the drug development process, the university is seeking to make its research more competitive for industry partnerships and FDA approval. Expect to see treatments for common diseases coming from this hub in the future, improving the quality of life for millions.

Stay tuned for more groundbreaking news from VCU.

Go!